Upadacitinib Delivers Durable 1-Year Benefits in Real-World UC
(MedPage Today) -- LAS VEGAS -- Upadacitinib (Rinvoq) demonstrated durable clinical, endoscopic, and histologic benefit in a large real-world cohort ...
Tag: Durable
(MedPage Today) -- LAS VEGAS -- Upadacitinib (Rinvoq) demonstrated durable clinical, endoscopic, and histologic benefit in a large real-world cohort ...